Detalhe da pesquisa
1.
Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.
N Engl J Med
; 389(24): 2233-2244, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38091530
2.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
3.
Safety, Tolerability and Immunogenicity of a mRNA-based RSV Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial.
J Infect Dis
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298125
4.
Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase I Clinical Trial in Healthy Older Adults.
J Infect Dis
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38385566
5.
A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopes.
J Virol
; 88(20): 11802-10, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25078705
6.
A cationic nanoemulsion for the delivery of next-generation RNA vaccines.
Mol Ther
; 22(12): 2118-2129, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25027661
7.
Nonviral delivery of self-amplifying RNA vaccines.
Proc Natl Acad Sci U S A
; 109(36): 14604-9, 2012 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22908294
8.
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
Proc Natl Acad Sci U S A
; 108(23): 9619-24, 2011 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-21586636
9.
Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children.
Pediatrics
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38738290
10.
A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults.
Vaccine
; 41(26): 3898-3906, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210308
11.
Evaluation of a stabilized RSV pre-fusion F mRNA vaccine: Preclinical studies and Phase 1 clinical testing in healthy adults.
Vaccine
; 41(44): 6488-6501, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37777449
12.
H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes.
J Exp Med
; 203(2): 383-91, 2006 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16461341
13.
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.
Open Forum Infect Dis
; 9(7): ofac206, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35794943
14.
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.
Hum Vaccin Immunother
; 17(5): 1248-1261, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33121346
15.
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection.
NPJ Vaccines
; 5(1): 16, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128257
16.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.
bioRxiv
; 2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577634
17.
Antigen delivered by anthrax lethal toxin induces the development of memory CD8+ T cells that can be rapidly boosted and display effector functions.
Infect Immun
; 76(3): 1214-22, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18086810
18.
Both CD4+ and CD8+ T cells respond to antigens fused to anthrax lethal toxin.
Infect Immun
; 76(6): 2603-11, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18347032
19.
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity.
Vaccine
; 36(12): 1689-1699, 2018 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29456015
20.
Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity.
Virology
; 447(1-2): 254-64, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24210122